Invention Grant
- Patent Title: Blinding kit for clinical trials
-
Application No.: US14371788Application Date: 2013-01-15
-
Publication No.: US09861312B2Publication Date: 2018-01-09
- Inventor: Claus Cordes
- Applicant: Sanofi-Aventis Deutschland GmbH
- Applicant Address: DE Frankfurt am Main
- Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP12151197 20120116
- International Application: PCT/EP2013/050643 WO 20130115
- International Announcement: WO2013/107725 WO 20130725
- Main IPC: A61B5/00
- IPC: A61B5/00 ; A61M5/14 ; A61M5/00 ; A61M5/20 ; A61M5/315 ; A61M5/31

Abstract:
The present invention relates to a blinding kit for administering a medicament to a patient in a clinical trial, the blinding kit comprising: a first blinding device having an opaque container and having an outlet for administering a liquid substance to a patient and having at least a first and a second inlet, wherein the first inlet is in permanent fluid communication with the outlet and wherein at least the second inlet is disconnected from the outlet, a second blinding device having an opaque container and having an outlet for administering a liquid substance to a patient and having at least two inlets, wherein said at least two inlets are in permanent fluid communication with the outlet.
Public/Granted literature
- US20140350486A1 Blinding Kit for Clinical Trials Public/Granted day:2014-11-27
Information query